202 related articles for article (PubMed ID: 19538167)
1. Titanium and vanadium complexes as anticancer agents.
Kostova I
Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
[TBL] [Abstract][Full Text] [Related]
2. Titanium complexes in cancer treatment.
Meléndez E
Crit Rev Oncol Hematol; 2002 Jun; 42(3):309-15. PubMed ID: 12050022
[TBL] [Abstract][Full Text] [Related]
3. Health Benefits of Vanadium and Its Potential as an Anticancer Agent.
Crans DC; Yang L; Haase A; Yang X
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394028
[TBL] [Abstract][Full Text] [Related]
4. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
5. Spermicidal activity of metallocene complexes containing vanadium(IV) in humans.
D'Cruz OJ; Ghosh P; Uckun FM
Biol Reprod; 1998 Jun; 58(6):1515-26. PubMed ID: 9623614
[TBL] [Abstract][Full Text] [Related]
6. Vanadium in cancer treatment.
Evangelou AM
Crit Rev Oncol Hematol; 2002 Jun; 42(3):249-65. PubMed ID: 12050018
[TBL] [Abstract][Full Text] [Related]
7. Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.
Köpf-Maier P; Krahl D
Chem Biol Interact; 1983 Jun; 44(3):317-28. PubMed ID: 6872095
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.
Kowalski S; Wyrzykowski D; Inkielewicz-Stępniak I
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290299
[TBL] [Abstract][Full Text] [Related]
9. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
10. Cell Arrest and Apoptosis Induced by the Next Generation of Vanadium Based Drugs: Action Mechanism to Structure Relation and Future Perspectives.
Vlasiou MC; Pafiti KS
Anticancer Agents Med Chem; 2021 Oct; 21(16):2111-2116. PubMed ID: 33355058
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of vanadium compounds.
Djordjevic C
Met Ions Biol Syst; 1995; 31():595-616. PubMed ID: 8564819
[No Abstract] [Full Text] [Related]
13. Antitumour metallocenes: structure-activity studies and interactions with biomolecules.
Harding MM; Mokdsi G
Curr Med Chem; 2000 Dec; 7(12):1289-303. PubMed ID: 11032972
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
15. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
16. Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides.
Köpf-Maier P; Wagner W; Köpf H
Naturwissenschaften; 1981 May; 68(5):272-3. PubMed ID: 7242686
[No Abstract] [Full Text] [Related]
17. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
18. Potential use of vanadium compounds in therapeutics.
Barrio DA; Etcheverry SB
Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
Crans DC
J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
